Author:
Devogelaer Jean-Pierre,Geusens Piet,Daci Evis,Gielen Evelien,Denhaerynck Kris,MacDonald Karen,Hermans Christine,Vancayzeele Stefaan,Abraham Ivo,Boonen Steven
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget’s disease of bone. Lancet 372:155–163
2. Michou L, Brown JP (2011) Emerging strategies and therapies for treatment of Paget’s disease of bone. Drug Des Devel Ther 5:225–239
3. Reid IR, Hosking DJ (2011) Bisphosphonates in Paget’s disease. Bone 49:89–94
4. Devogelaer JP, Nagant de Deuxchaisnes C (2003) Paget’s disease of bone. In: Hochberg MC, Silman AJ, Smolen JS et al (eds) Rheumatology, vol 2, 3rd edn. Mosby, London, pp 2139–2147
5. Green JR, Rogers MJ (2002) Pharmacologic profile of zoledronic acid: a highly potent inhibitor of bone resorption. Drug Dev Res 55:210–224
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献